Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 049134/0710 | |
| Pages: | 7 |
| | Recorded: | 05/10/2019 | | |
| Attorney Dkt #: | 54993USCNT; 54993USPCTD |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15385088
|
Filing Dt:
|
12/20/2016
|
|
Publication #:
|
|
Pub Dt:
|
10/26/2017
| | | | |
|
Title:
|
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16259419
|
Filing Dt:
|
01/28/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/04/2019
| | | | |
|
Title:
|
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
|
|
|
Assignee
|
|
|
|
|
| 250 MASSACHUSETTS AVE. |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
Correspondence name and address
|
| |
MARK LAZAROW
|
| |
ONE HEALTH PLAZA
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
05/14/2024 09:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
